| Dr Constance Anne Catellani, MD | |
|
7830 Kilbourn Ave, South Entrance, Skokie, IL 60076-3512 | |
| (847) 673-5300 | |
| (847) 673-7063 |
| Full Name | Dr Constance Anne Catellani |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 47 Years |
| Location | 7830 Kilbourn Ave, Skokie, Illinois |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043351745 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 036057626 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| American Home Care Express Inc | Lincolnwood, IL | Home health agency |
| Chicago Health, Inc | Park ridge, IL | Home health agency |
| Northshore University Healthsystem - Evanston Hospital | Evanston, IL | Hospital |
| Entity Name | C A Catellani M D S C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184925463 PECOS PAC ID: 0143417949 Enrollment ID: O20101206000942 |
News Archive
BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion.
Dominion Diagnostics has recently developed and validated one of the first clinical urine drug monitoring assays to detect the metabolites of JWH-018 and JWH-073, two compounds typically found in synthetic cannabinoids, also referred to as "herbal incense" products.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the closing of the sale to a single institutional investor of 21,130,400 shares of its common stock and warrants to purchase up to 10,565,200 additional shares of its common stock.
Researchers in the Cardiovascular Innovation Institute, a partnership between the University of Louisville and Jewish Hospital, in collaboration with researchers at Indiana University and Purdue University, have received a $2,027,059 grant from the National Institutes of Health to further develop an implantable pump that could dramatically improve the lives of patients with single ventricle heart disease.
Women who have ovarian cancer often develop a condition called ascites, which is a buildup of fluids in the abdomen. The most common treatment for ascites is puncturing the abdomen and manually draining the fluid, which is painful and risky and must be repeated every few weeks.
› Verified 1 days ago
| Entity Name | Simpkins Medical Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215669270 PECOS PAC ID: 3274915830 Enrollment ID: O20220729001785 |
News Archive
BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion.
Dominion Diagnostics has recently developed and validated one of the first clinical urine drug monitoring assays to detect the metabolites of JWH-018 and JWH-073, two compounds typically found in synthetic cannabinoids, also referred to as "herbal incense" products.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the closing of the sale to a single institutional investor of 21,130,400 shares of its common stock and warrants to purchase up to 10,565,200 additional shares of its common stock.
Researchers in the Cardiovascular Innovation Institute, a partnership between the University of Louisville and Jewish Hospital, in collaboration with researchers at Indiana University and Purdue University, have received a $2,027,059 grant from the National Institutes of Health to further develop an implantable pump that could dramatically improve the lives of patients with single ventricle heart disease.
Women who have ovarian cancer often develop a condition called ascites, which is a buildup of fluids in the abdomen. The most common treatment for ascites is puncturing the abdomen and manually draining the fluid, which is painful and risky and must be repeated every few weeks.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Constance Anne Catellani, MD 7830 Kilbourn Ave, Skokie, IL 60076-3512 Ph: (847) 673-5300 | Dr Constance Anne Catellani, MD 7830 Kilbourn Ave, South Entrance, Skokie, IL 60076-3512 Ph: (847) 673-5300 |
News Archive
BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion.
Dominion Diagnostics has recently developed and validated one of the first clinical urine drug monitoring assays to detect the metabolites of JWH-018 and JWH-073, two compounds typically found in synthetic cannabinoids, also referred to as "herbal incense" products.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the closing of the sale to a single institutional investor of 21,130,400 shares of its common stock and warrants to purchase up to 10,565,200 additional shares of its common stock.
Researchers in the Cardiovascular Innovation Institute, a partnership between the University of Louisville and Jewish Hospital, in collaboration with researchers at Indiana University and Purdue University, have received a $2,027,059 grant from the National Institutes of Health to further develop an implantable pump that could dramatically improve the lives of patients with single ventricle heart disease.
Women who have ovarian cancer often develop a condition called ascites, which is a buildup of fluids in the abdomen. The most common treatment for ascites is puncturing the abdomen and manually draining the fluid, which is painful and risky and must be repeated every few weeks.
› Verified 1 days ago
Dr. Herman Blomeier, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9977 Woods Dr, Skokie, IL 60077 Phone: 847-663-8540 Fax: 847-663-1015 | |
Mark B Lampert, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9977 Woods Dr, 3rd Floor, Skokie, IL 60077 Phone: 847-663-8410 Fax: 847-663-8411 | |
Dr. Julia Rozovsky Weinberger, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 9700 N Kenton, #306, Skokie, IL 60076 Phone: 847-679-8470 | |
Dr. Marni Hope Goldberg, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9150 N. Crawford Ave. Suite 203, Skokie, IL 60076 Phone: 847-674-2251 Fax: 847-674-2253 | |
Dr. Katarzyna Zarnecki, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9977 Woods Dr, Skokie, IL 60077 Phone: 847-663-8540 Fax: 847-663-1015 | |
Dr. Kristina Ivanova Todorova-koteva, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9977 Woods Dr Ste 300, Skokie, IL 60077 Phone: 847-663-8540 |